VINO - BTAI SXTC and FRLN among pre-market losers
2023-10-05 08:16:47 ET
More on BioXcel Therapeutics, Lithium Americas Corp., etc.
- Lithium Americas (Argentina): An Outrageously Undervalued Lithium Company
- BioXcel: Navigating The Peaks And Valleys Of Regulatory Uncertainties
- BioXcel's Struggles: From FDA Issues To Financial Instability
- BioXcel shares jump 9% following update on FDA meetings, patents
- Mizuho cuts BioXcel to neutral, cites reduced expectations for lead drug
For further details see:
BTAI, SXTC and FRLN among pre-market losers